1-2 of 2
Adam Foley-Comer
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

DSP107, a Novel Bi-Functional Fusion Protein That Combines Inhibition of CD47 with Targeted Activation of 4-1BB to Trigger Innate and Adaptive Anticancer Immune Responses

Ewa Cendrowicz, PhD, Lisa Jacob, Shirley Greenwald, Ami Tamir, Yosi Gozlan, Gerwin Huls, MD PhD, Adam Foley-Comer, Yaron Pereg, Ayelet Chajut, Amnon Peled, PhD, Edwin Bremer, PhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 19–20.
https://doi.org/10.1182/blood-2020-140280
Published: 2020
Journal Articles

BL-8040, a Peptidic CXCR4 Antagonist, Induces Leukemia Cell Death and Specific Leukemia Cell Mobilization in Relapsed/Refractory Acute Myeloid Leukemia Patients in an Ongoing Phase IIa Clinical Trial

Gautam Borthakur, MD, Arnon Nagler, MD, Yishai Ofran, MD, Jacob M. Rowe, MD, Jessica K. Altman, MD, Olga Frankfurt, MD, Martin S. Tallman, MD, Irit Avivi, Amnon Peled, PhD, Yaron Pereg, PhD, Adam Foley-Comer, MD, Lena Russovsky, BS, Arnon Aharon, MD, Teresa McQueen, BS, Naveen Pemmaraju, MD, Carlos E. Bueso-Ramos, MD PhD, Jorge E. Cortes, MD, Michael Andreeff, MD PhD
Journal: Blood
Blood (2014) 124 (21): 950.
https://doi.org/10.1182/blood.V124.21.950.950
Published: 2014